Vortrag
Are M&As Spurring or Stifling Innovation? Evidence from Antidiabetic Drug Development

Jo Seldeslachts, Jan Malek, Reinhilde Veugelers


Compass Lexecon
Berlin, 20.03.2025




keyboard_arrow_up